IntroductionAs the shift towards translational research continues, the pharmaceutical industry is accelerating its spending on business intelligence (BI).
This Datamonitor report forecasts and analyzes the IT opportunity for vendors serving the Big Pharma and Biotech segments.
Analysis includes industry and technology trends, market forecast, and forecast by technology, geography and end-user segments.ScopeHighlightsReasons to PurchaseMonitor shifts in IT investments that pharmaceutical organizations are making Identify the most promising sub-segments of the pharmaceutical industry for your company's offerings Understand high-level shifts and implications in the Big Pharma and Biotech segments